Sihan Wu
机构: Children’s Medical Center Research Institute, University of Texas Southwestern Medical Center
主页: utsw.edu
每年引用次数
引用次数
引用: 2,586
H-指数: 25
I10-指数 : 29
出版物: 38
Inhibition of cancer cell proliferation by midazolam by targeting transient receptor potential melastatin 7
YUNLING DOU , YUAN LI , JINGKAO CHEN , SIHAN WU
Oncology Letters 5 ( 3) 1010 -1016
22
2013
Extrachromosomal DNA (ecDNA) in cancer pathogenesis.
Paul S Mischel , Vineet Bafna , Sihan Wu
Current Opinion in Genetics & Development 66 78 -82
17
2021
Activation of a pro-survival pathway IL-6/JAK2/STAT3 contributes to glial fibrillary acidic protein induction during the cholera toxin-induced differentiation of C6 malignant glioma cells
Minfeng Shu , Yuxi Zhou , Wenbo Zhu , Sihan Wu
Molecular Oncology 5 ( 3) 265 -272
27
2011
Targeting cancer's metabolic co-dependencies: A landscape shaped by genotype and tissue context.
Junfeng Bi , Sihan Wu , Wenjing Zhang , Paul S. Mischel
Biochimica et Biophysica Acta 1870 ( 1) 76 -87
29
2018
Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells
Minfeng Shu , Xiaoke Zheng , Sihan Wu , Huimin Lu
Molecular Cancer 10 ( 1) 59 -59
96
2011
Zinc-finger antiviral protein acts as a tumor suppressor in colorectal cancer
Jing Cai , Wenfeng Liu , Chun Wa Wong , Wenbo Zhu
Oncogene 39 ( 37) 5995 -6008
1
2020
EcDNA hubs drive cooperative intermolecular oncogene expression
King L Hung , Kathryn E Yost , Liangqi Xie , Quanming Shi
bioRxiv
65
2020
Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets.
Junfeng Bi , Sudhir Chowdhry , Sihan Wu , Wenjing Zhang
Nature Reviews Cancer 20 ( 1) 57 -70
156
2020
Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity
Ciro Zanca , Genaro R. Villa , Jorge A. Benitez , Amy Haseley Thorne
Genes & Development 31 ( 12) 1212 -1227
30
2017
Transcriptional upregulation of microtubule-associated protein 2 is involved in the protein kinase A-induced decrease in the invasiveness of glioma cells
Yuxi Zhou , Sihan Wu , Chaofeng Liang , Yuan Lin
Neuro-oncology 17 ( 12) 1578 -1588
25
2015
Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling
Junfeng Bi , Taka-Aki Ichu , Ciro Zanca , Huijun Yang
Cell Metabolism 30 ( 3) 525
36
2019
Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers.
Hoon Kim , Nam-Phuong Nguyen , Kristen Turner , Sihan Wu
Nature Genetics 52 ( 9) 891 -897
168
2020
Triptolide inhibits proliferation and invasion of malignant glioma cells
Haipeng Zhang , Wenbo Zhu , Xingwen Su , Sihan Wu
Journal of Neuro-oncology 109 ( 1) 53 -62
20
2012
Same Script, Different Cast: Different Cell Origins Shape Molecular Features and Therapeutic Response in Glioblastoma.
Sihan Wu , Paul S. Mischel
Cancer Cell 38 ( 3) 311 -313
1
2020
The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes
Fan Xing , Yizhao Luan , Jing Cai , Sihan Wu
Cell Reports 18 ( 2) 468 -481
81
2017
MicroRNA 335 Is Required for Differentiation of Malignant Glioma Cells Induced by Activation of cAMP/Protein Kinase A Pathway
Minfeng Shu , Yuehan Zhou , Wenbo Zhu , Haipeng Zhang
Molecular Pharmacology 81 ( 3) 292 -298
62
2012
Evolvement of microRNAs as Therapeutic Targets for Malignant Gliomas
Sihan Wu , Wenbo Zhu , Guangmei Y
InTech
2
2013
Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers.
Yuan Lin , Haipeng Zhang , Jiankai Liang , Kai Li
Proceedings of the National Academy of Sciences of the United States of America 111 ( 42)
121
2014
Single Bout Short Duration Fluid Shear Stress Induces Osteogenic Differentiation of MC3T3-E1 Cells via Integrin β1 and BMP2 Signaling Cross-Talk
Zhihui Mai , Zhuli Peng , Sihan Wu , Jinglan Zhang
PLOS ONE 8 ( 4)
19
2013
Circular ecDNA promotes accessible chromatin and high oncogene expression
Sihan Wu , Kristen M. Turner , Nam Nguyen , Ramya Raviram
Nature 575 ( 7784) 699 -703
244
2019